IL-1-话题@MedSci

#IL-1#

184篇内容 | 4455人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1508173, encodeId=7b3215081e313, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Stroke：高水平IL-16可降低人类动脉粥样硬化的风险, objectType=article, longId=55676, objectId=1340556e6d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1340556e6d9, replyNumber=0, likeNumber=71, createdTime=2015-09-03, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1340556e6d9, moduleTitle=Stroke：高水平IL-16可降低人类动脉粥样硬化的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1340556e6d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508172, encodeId=672e15081e224, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Stem Cells：经IL-17处理的干细胞可能控制移植病人的排斥反应, objectType=article, longId=52897, objectId=59365289ea8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59365289ea8, replyNumber=0, likeNumber=55, createdTime=2015-07-07, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59365289ea8, moduleTitle=Stem Cells：经IL-17处理的干细胞可能控制移植病人的排斥反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59365289ea8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508171, encodeId=f60015081e151, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=The Lancet：单抗药物ixekizumab中和白介素IL-17A 成功治疗银屑病, objectType=article, longId=52031, objectId=a0e8520314d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0e8520314d, replyNumber=0, likeNumber=60, createdTime=2015-06-14, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0e8520314d, moduleTitle=The Lancet：单抗药物ixekizumab中和白介素IL-17A 成功治疗银屑病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0e8520314d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508170, encodeId=6bd115081e0d6, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=礼来IL-17A单抗ixekizumab银屑病关节炎III期成功, objectType=article, longId=49722, objectId=d82a49e227a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d82a49e227a, replyNumber=0, likeNumber=45, createdTime=2015-04-24, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d82a49e227a, moduleTitle=礼来IL-17A单抗ixekizumab银屑病关节炎III期成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d82a49e227a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508169, encodeId=2a8c150816916, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Immunity：IL-22调节回肠炎感染应中IL-18的产生, objectType=article, longId=47648, objectId=62a04e64827, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62a04e64827, replyNumber=0, likeNumber=58, createdTime=2015-03-05, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62a04e64827, moduleTitle=Immunity：IL-22调节回肠炎感染应中IL-18的产生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62a04e64827)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508168, encodeId=536815081681d, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Clin Cancer Res：IL-10基因装备病毒有望更好治疗胰腺癌, objectType=article, longId=44772, objectId=502e44e7206, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=502e44e7206, replyNumber=0, likeNumber=55, createdTime=2014-12-31, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=502e44e7206, moduleTitle=Clin Cancer Res：IL-10基因装备病毒有望更好治疗胰腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=502e44e7206)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508167, encodeId=bf78150816e62, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=诺华单抗Cosentyx将于2015年初上市，将成为IL-17阻断剂, objectType=article, longId=43163, objectId=6a714316374, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a714316374, replyNumber=0, likeNumber=126, createdTime=2014-11-28, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a714316374, moduleTitle=诺华单抗Cosentyx将于2015年初上市，将成为IL-17阻断剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a714316374)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508166, encodeId=842a15081661b, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Pediatr Crit Care Med：IL-1受体拮抗剂阿那白滞素有望治疗危重血液病儿童患者, objectType=article, longId=37761, objectId=41e33e76137, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41e33e76137, replyNumber=0, likeNumber=61, createdTime=2014-07-13, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41e33e76137, moduleTitle=Pediatr Crit Care Med：IL-1受体拮抗剂阿那白滞素有望治疗危重血液病儿童患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41e33e76137)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508165, encodeId=2bc1150816574, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Nature：IL-1与干扰素联手调用免疫系统对抗结核病菌, objectType=article, longId=37445, objectId=ab5c3e445ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab5c3e445ef, replyNumber=0, likeNumber=79, createdTime=2014-07-06, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab5c3e445ef, moduleTitle=Nature：IL-1与干扰素联手调用免疫系统对抗结核病菌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab5c3e445ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508164, encodeId=5977150816483, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=牛皮癣新药IL-17受体单抗brodalumab三期研究获得成功, objectType=article, longId=34817, objectId=57b53481e9f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57b53481e9f, replyNumber=0, likeNumber=0, createdTime=2014-05-17, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57b53481e9f, moduleTitle=牛皮癣新药IL-17受体单抗brodalumab三期研究获得成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57b53481e9f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508163, encodeId=d6f5150816390, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=STM：IL-17细胞因子在LAD-相关性牙骨质流失中起着关键性的作用, objectType=article, longId=32801, objectId=cac43280177, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cac43280177, replyNumber=0, likeNumber=73, createdTime=2014-04-04, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cac43280177, moduleTitle=STM：IL-17细胞因子在LAD-相关性牙骨质流失中起着关键性的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cac43280177)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508162, encodeId=a1531508162c0, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Ann Rheum Dis :抗IL-17A单克隆抗体可能用于治疗银屑病关节炎, objectType=article, longId=29532, objectId=275c29532df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=275c29532df, replyNumber=0, likeNumber=128, createdTime=2014-01-19, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=275c29532df, moduleTitle=Ann Rheum Dis :抗IL-17A单克隆抗体可能用于治疗银屑病关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=275c29532df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508161, encodeId=a1bd150816133, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Nat Med：阻断IL-1b或有助治疗肥胖型哮喘, objectType=article, longId=29399, objectId=62eb2939954, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62eb2939954, replyNumber=0, likeNumber=66, createdTime=2014-01-16, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62eb2939954, moduleTitle=Nat Med：阻断IL-1b或有助治疗肥胖型哮喘, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62eb2939954)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508160, encodeId=aa1a1508160e7, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=STM：IL-17在心血管斑块上“敷上创可贴”, objectType=article, longId=22472, objectId=f5d9224e20e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5d9224e20e, replyNumber=0, likeNumber=79, createdTime=2013-08-03, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5d9224e20e, moduleTitle=STM：IL-17在心血管斑块上“敷上创可贴”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5d9224e20e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508159, encodeId=0f5a150815955, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=IL-17及血浆水平与HCV感染的关系, objectType=article, longId=21999, objectId=0c53219998d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c53219998d, replyNumber=0, likeNumber=69, createdTime=2013-07-26, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c53219998d, moduleTitle=IL-17及血浆水平与HCV感染的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c53219998d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508158, encodeId=d6cd150815836, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=J Immunol：IL-13受体在帕金森氏病患者多巴胺能神经元损伤中扮演关键作用, objectType=article, longId=12731, objectId=217212e3161, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=217212e3161, replyNumber=0, likeNumber=108, createdTime=2012-12-12, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=217212e3161, moduleTitle=J Immunol：IL-13受体在帕金森氏病患者多巴胺能神经元损伤中扮演关键作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=217212e3161)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508157, encodeId=29cb150815eed, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=Cancer Cell: IL-15可能是慢性炎症致癌的重要机制, objectType=article, longId=11102, objectId=1c1511102cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c1511102cd, replyNumber=0, likeNumber=47, createdTime=2012-11-18, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c1511102cd, moduleTitle=Cancer Cell: IL-15可能是慢性炎症致癌的重要机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c1511102cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508156, encodeId=9cf715081569a, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=NEJM：IL-17可能成为银屑病治疗的靶点, objectType=article, longId=4922, objectId=27414922ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27414922ab, replyNumber=0, likeNumber=87, createdTime=2012-04-12, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27414922ab, moduleTitle=NEJM：IL-17可能成为银屑病治疗的靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27414922ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508155, encodeId=a0bd15081552c, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=IL-1调节破骨细胞生成的新奇机制, objectType=article, longId=4763, objectId=a9dd4e63c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9dd4e63c4, replyNumber=0, likeNumber=69, createdTime=2012-04-12, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9dd4e63c4, moduleTitle=IL-1调节破骨细胞生成的新奇机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9dd4e63c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1508154, encodeId=2487150815496, content=<a href='/topic/show?id=8d4596248e' target=_blank style='color:#2F92EE;'>#IL-1#</a>, objectTitle=PLoS One：中国汉族乳腺癌与IL-17多态性关联分析, objectType=article, longId=4511, objectId=cfe045119f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfe045119f, replyNumber=0, likeNumber=0, createdTime=2012-04-04, rootId=0, userName=jjjiang0202, userId=f6cf9946833, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfe045119f, moduleTitle=PLoS One：中国汉族乳腺癌与IL-17多态性关联分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfe045119f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

IL-1

2020-05-29

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Stroke：高水平IL-16可降低人类动脉粥样硬化的风险

2015-09-03

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Stem Cells：经IL-17处理的干细胞可能控制移植病人的排斥反应

2015-07-07

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

The Lancet：单抗药物ixekizumab中和白介素IL-17A 成功治疗银屑病

2015-06-14

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

礼来IL-17A单抗ixekizumab银屑病关节炎III期成功

2015-04-24

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Immunity：IL-22调节回肠炎感染应中IL-18的产生

2015-03-05

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Clin Cancer Res：IL-10基因装备病毒有望更好治疗胰腺癌

2014-12-31

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

诺华单抗Cosentyx将于2015年初上市，将成为IL-17阻断剂

2014-11-28

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Pediatr Crit Care Med：IL-1受体拮抗剂阿那白滞素有望治疗危重血液病儿童患者

2014-07-13

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Nature：IL-1与干扰素联手调用免疫系统对抗结核病菌

2014-07-06

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

牛皮癣新药IL-17受体单抗brodalumab三期研究获得成功

2014-05-17

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

STM：IL-17细胞因子在LAD-相关性牙骨质流失中起着关键性的作用

2014-04-04

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Ann Rheum Dis :抗IL-17A单克隆抗体可能用于治疗银屑病关节炎

2014-01-19

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Nat Med：阻断IL-1b或有助治疗肥胖型哮喘

2014-01-16

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

STM：IL-17在心血管斑块上“敷上创可贴”

2013-08-03

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

IL-17及血浆水平与HCV感染的关系

2013-07-26

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

J Immunol：IL-13受体在帕金森氏病患者多巴胺能神经元损伤中扮演关键作用

2012-12-12

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

Cancer Cell: IL-15可能是慢性炎症致癌的重要机制

2012-11-18

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

NEJM：IL-17可能成为银屑病治疗的靶点

2012-04-12

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

IL-1调节破骨细胞生成的新奇机制

2012-04-12

jjjiang0202 (审核中...)

前往app查看评论内容

#IL-1#

PLoS One：中国汉族乳腺癌与IL-17多态性关联分析

2012-04-04

科室
- - 订阅+
  - 更多科室
工具
服务